Inhibition of farnesyl protein transferase--a review of the recent patent literature.
The inhibition of farnesyl protein transferase (FPT) has been the subject of intense research over the last few years and offers a promising approach to non-cytotoxic, anticancer therapy. Several FPT inhibitors are currently in clinical trials for anticancer therapy. This paper reviews the patent applications that appeared from January to July 2001. A brief summary of the compounds in clinical evaluation is also given.